Mesothelioma Cancer Resources Blog
-
The Impact of Lymph Node Station on Survival in 348 Patients with Surgically Resected Malignant Pleural Mesothelioma
Source: The Journal of Thoracic and Cardiovascular Surgery Full Title: The Impact of Lymph Node Station on Survival in 348 Patients with Surgically Resected Malignant Pleural Mesothelioma: Implications for Revision of the American Joint Committee on Cancer Staging System The current system for staging cases of pleural mesothelioma is based on a TNM model, where …
Label: Mesothelioma Pleural Mesothelioma
Posted on Wednesday, Oct 15, 2008 -
Treatment of Peritoneal Mesothelioma in Pediatric Patients
Source: Pediatric Blood & Cancer Malignant Mesothelioma is most commonly a disease of the older and the elderly. The vast majority of all mesothelioma diagnoses are for men and women (although, mainly men), older that 55 or 60. However, the disease can, albeit very rarely, affect teenagers and young adults. Because mesothelioma is so rarely …
Label: Mesothelioma Treatments
Posted on Thursday, Oct 9, 2008 -
Lilly says FDA widens use of cancer drug Alimta
Source: CNNMoney.com Eli Lilly has announced that its cancer drug Alimta, when used in combination with cisplatin, has received FDA approval for the first-line treatment of “locally-advanced and metastatic non-small cell lung cancer (NSCLC), for patients with nonsquamous histology.” The FDA’s new approval is the third overall approval that Alimta has received, and the second …
Posted on Wednesday, Oct 1, 2008
Mike is a licensed attorney and the former editor of North Carolina Lawyers Weekly and South Carolina Lawyers Weekly. He has contributed numerous articles to the North Carolina State Bar Journal and is a co-author of Capital Lawyers, a history of the Wake County (NC) Bar.
Gregory Froom is a licensed North Carolina attorney and the former editor of North Carolina Lawyers Weekly and South Carolina Lawyers Weekly.